Development and manufacture of viral vectors for genetic vaccines and advanced therapies
The Italian SME is a CDMO (contract development manufacturing organisation) specialized in developing biomedical products for advanced therapies and genetic vaccines. The company offers customized solutions based on client's requirements from early development to manufacture and clinical release. The company is seeking research and technical cooperation agreements with Pharma or Biotech companies dedicated to gene therapy or genetic vaccines that need to develop or produce viral vectors
The SME is seeking for research and technical cooperation agreements with primary pharma or biotech companies. the SME offers processes and capability already tested and proved that need dedicated for gene therapy or genetic vaccines. Especially for those that need to develop or to be produced by mean of viral vectors.
The SME company's management and scientific teams have successfully developed genetic vaccines against several infectious diseases through a highly innovative adenovirus-based platform. These vaccines have been evaluated in thousands of healthy subjects of all ages, as well as in patients with chronic viral infections and shown to be safe and highly immunogenic. The company has R&D laboratories specialized in the isolation and genetic manipulation of wild-type viruses through vectorization and transgene engineering. Additionally, the company has state-of-the-art technologies and expertise to evaluate the immunological responses to viral vectors in samples from preclinical models and clinical studies. Over the last years the company has developed a unique expertise in the process development and in the large-scale GMP production of viral vectors such as MVA (Modified Vaccine AnKara), AAV (adeno-associated virus) and adenovirus. The good manufacturing practices (GMP) manufacturing facility meets the most stringent criteria to produce material to be used in human clinical studies. The company has a well proven ability to develop for main-pharmaceutical actors clinical batches of viral vector-based medicinal products. The SME is seeking for research and technical cooperation agreements with primary pharma or biotech companies that need dedicated and specialized collaboration for gene therapy or genetic vaccines that need to develop or to be produced by mean of viral vectors.
Advantages and innovations
The italian SME proposes innovative approaches to the development of novel viral platforms through isolation of novel virus strains from human and non-human species and vector engineering. Additionally, the SME offers a state-of-the-art, fully-equipped multiproduct GMP facility service equipped with quality control laboratories, inclusive of filling suite with a fully automated aseptic filling machine. The advantages offered by the processes are: - Unique expertise in large-scale GMP viral cell culture, up to a 200L scale and concomitant GMP activities. - Large capabilities to accommodate different upstream platform by using wave technologies as well as a stirrer tank bioreactor (STR- bioreactyor) for suspensions cells or different incubators for adherent cells amplification. - Robust expertise in downstream process by applying large scale clarification by using depth filters. Molecules separation by applying chromatographic techniques on different instruments like Akta-pilot, Akta-process or fully disposable Akta-ready equipped with both resins or membranes. -Solid experience in ultrafiltration techniques by applying tangential flow filtration on different instruments like spectrum KPM (kernel polynomial method), Cogent Millipore equipped with both hollow fibers or cassettes. -Unique expertise in validation of the aseptic process for clinical bulk Drug Substance (DS) and clinical Drug Product (DP) manufacturing. - Large viral vector manufacturing portfolio
Intellectual Property Rights (IPR)
Register your interest
How it works
- Tell us about yourself
- We’ll discuss with you
- We put the right partners in touch
EEN help you find the right partner, rather than you going it alone.
Our role is to review and collate the most suitable submissions, and then send them to the client who posted the opportunity. We consult with you, and the client, to make the process professional and easy.
These are live opportunities. Your registration of interest on the site is just like a professional approach to a business at a networking event. To stand the best chance of success, make your submission really sing. Sell why the client who posted the opportunity should work with you. Excite them. Ask questions. Try and avoid copy and pasting words from elsewhere.
Once the client has chosen their partner, we'll introduce them over email and keep in touch with both parties to see how it's going. Sometimes things progress quickly. Sometimes because of changing priorities for either party, things progress slowly, but you never know - your next big business break could start right here.
First we need to check you’re human.
Thank you for verifying your email. We have sent you a confirmation email containing a 6 digit verification code to unlock the form below